News | Asteri Pharma

LATEST NEWS

A lack of knowledge about movement disorders compounds the challenges faced by patients with its rarest forms. Support #MoveDisorder Day.

Nov 23, 20233 min read

If you’re working in the CNS or sleep disorder space and looking to navigate the Australian market better, Asteri are committed to your caus

Sep 22, 20232 min read

With a #strongerPBS, we all benefit together - patients, clinicians, politicians, and industry, by having access to new treatments earlier.

Sep 16, 20233 min read

Do we need to look at the protocols for rare diseases differently? There’s too great a cost to our society if we continue the way we are.

Jul 20, 20232 min read

A new report assess the effect of long-run changes in the drugs provided by the PBS on mortality and hospital utilisation in Australia.

Jul 6, 20232 min read

The Asteri team had the pleasure of joining over 1,500 delegates in attending the ARCS 2023 conference last week.

Jun 15, 20232 min read

Asteri catches up with exciting partners and reviews cutting-edge research at AAN's annual conference this week.

Apr 22, 20231 min read

Pharma in Focus celebrates new CEO's commitment to Australia market

Apr 11, 20231 min read

Rare Disease Company Coalition releases data regarding needs and opportunities within the rare disease community.

Apr 3, 20231 min read